Advice on the reassessment of axicabtagene ciloleucel (Yescarta®)
de boer J, Wijma S
Record ID 32018002690
Dutch
Details
Project Status:
Completed
Year Published:
2021
URL for published report:
https://english.zorginstituutnederland.nl/publications/reports/2021/07/26/advice-on-the-reassessment-of-axicabtagene-ciloleucel-yescarta
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
The Netherlands
MeSH Terms
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, B-Cell
- Biological Products
- Immunotherapy, Adoptive
- Receptors, Chimeric Antigen
- Antineoplastic Agents, Immunological
Contact
Organisation Name:
The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address:
Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name:
Timon Sibma
Contact Email:
TSibma@zinl.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.